201 related articles for article (PubMed ID: 28395882)
1. Should studies on Glanzmann thrombasthenia not be telling us more about cardiovascular disease and other major illnesses?
Nurden AT
Blood Rev; 2017 Sep; 31(5):287-299. PubMed ID: 28395882
[TBL] [Abstract][Full Text] [Related]
2. Expanding the Mutation Spectrum Affecting αIIbβ3 Integrin in Glanzmann Thrombasthenia: Screening of the ITGA2B and ITGB3 Genes in a Large International Cohort.
Nurden AT; Pillois X; Fiore M; Alessi MC; Bonduel M; Dreyfus M; Goudemand J; Gruel Y; Benabdallah-Guerida S; Latger-Cannard V; Négrier C; Nugent D; Oiron RD; Rand ML; Sié P; Trossaert M; Alberio L; Martins N; Sirvain-Trukniewicz P; Couloux A; Canault M; Fronthroth JP; Fretigny M; Nurden P; Heilig R; Vinciguerra C
Hum Mutat; 2015 May; 36(5):548-61. PubMed ID: 25728920
[TBL] [Abstract][Full Text] [Related]
3. Glanzmann thrombasthenia: state of the art and future directions.
Nurden AT; Pillois X; Wilcox DA
Semin Thromb Hemost; 2013 Sep; 39(6):642-55. PubMed ID: 23929305
[TBL] [Abstract][Full Text] [Related]
4. Novel mutations of integrin αIIb and β3 genes in Turkish children with Glanzmann's thrombasthenia.
Tokgoz H; Torun Ozkan D; Caliskan U; Akar N
Platelets; 2015; 26(8):779-82. PubMed ID: 25734216
[TBL] [Abstract][Full Text] [Related]
5. Understanding the genetic basis of Glanzmann thrombasthenia: implications for treatment.
Nurden AT; Pillois X; Nurden P
Expert Rev Hematol; 2012 Oct; 5(5):487-503. PubMed ID: 23146053
[TBL] [Abstract][Full Text] [Related]
6. Glanzmann thrombasthenia-like syndromes associated with Macrothrombocytopenias and mutations in the genes encoding the αIIbβ3 integrin.
Nurden AT; Pillois X; Fiore M; Heilig R; Nurden P
Semin Thromb Hemost; 2011 Sep; 37(6):698-706. PubMed ID: 22102273
[TBL] [Abstract][Full Text] [Related]
7. Glanzmann thrombasthenia: a review of ITGA2B and ITGB3 defects with emphasis on variants, phenotypic variability, and mouse models.
Nurden AT; Fiore M; Nurden P; Pillois X
Blood; 2011 Dec; 118(23):5996-6005. PubMed ID: 21917754
[TBL] [Abstract][Full Text] [Related]
8. In silico analysis of structural modifications in and around the integrin αIIb genu caused by ITGA2B variants in human platelets with emphasis on Glanzmann thrombasthenia.
Pillois X; Peters P; Segers K; Nurden AT
Mol Genet Genomic Med; 2018 Mar; 6(2):249-260. PubMed ID: 29385657
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic expression of the platelet-specific integrin, alphaIIbbeta3, in a murine model for Glanzmann thrombasthenia.
Fang J; Hodivala-Dilke K; Johnson BD; Du LM; Hynes RO; White GC; Wilcox DA
Blood; 2005 Oct; 106(8):2671-9. PubMed ID: 15972454
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of patients with Glanzmann thrombasthenia and identification of 17 novel mutations.
Sandrock-Lang K; Oldenburg J; Wiegering V; Halimeh S; Santoso S; Kurnik K; Fischer L; Tsakiris DA; Sigl-Kraetzig M; Brand B; Bührlen M; Kraetzer K; Deeg N; Hund M; Busse E; Kahle A; Zieger B
Thromb Haemost; 2015 Apr; 113(4):782-91. PubMed ID: 25373348
[TBL] [Abstract][Full Text] [Related]
11. Identification of one novel pathogenic
Lu Z; Nikuze L; Zhong Z; Li F; Zhang F; Liang K; Wei M; Wei H
Platelets; 2020; 31(3):355-359. PubMed ID: 31088191
[TBL] [Abstract][Full Text] [Related]
12. Immunisation against αIIbβ3 and αvβ3 in a type 1 variant of Glanzmann's thrombasthenia caused by a missense mutation Gly540Asp on β3.
Wihadmadyatami H; Röder L; Berghöfer H; Bein G; Heidinger K; Sachs UJ; Santoso S
Thromb Haemost; 2016 Aug; 116(2):262-71. PubMed ID: 27098940
[TBL] [Abstract][Full Text] [Related]
13. Alterations of the platelet proteome in type I Glanzmann thrombasthenia caused by different homozygous delG frameshift mutations in ITGA2B.
Loroch S; Trabold K; Gambaryan S; Reiß C; Schwierczek K; Fleming I; Sickmann A; Behnisch W; Zieger B; Zahedi RP; Walter U; Jurk K
Thromb Haemost; 2017 Feb; 117(3):556-569. PubMed ID: 28078347
[TBL] [Abstract][Full Text] [Related]
14. Diversity of Glanzmann thrombasthenia in southern India: 10 novel mutations identified among 15 unrelated patients.
Nelson EJ; Nair SC; Peretz H; Coller BS; Seligsohn U; Chandy M; Srivastava A
J Thromb Haemost; 2006 Aug; 4(8):1730-7. PubMed ID: 16879215
[TBL] [Abstract][Full Text] [Related]
15. A unique phenotype of acquired Glanzmann thrombasthenia due to non-function-blocking anti-αIIbβ3 autoantibodies.
Akuta K; Kashiwagi H; Yujiri T; Nishiura N; Morikawa Y; Kato H; Honda S; Kanakura Y; Tomiyama Y
J Thromb Haemost; 2019 Jan; 17(1):206-219. PubMed ID: 30388316
[TBL] [Abstract][Full Text] [Related]
16. First description of an IgM monoclonal antibody causing α
Pillois X; Guy A; Choquet É; James C; Tuffigo M; Viallard JF; Garcia C; Bordet JC; Jandrot-Perrus M; Payrastre B; Fiore M
J Thromb Haemost; 2019 May; 17(5):795-802. PubMed ID: 30868743
[TBL] [Abstract][Full Text] [Related]
17. A beta3 Asp217-->Val substitution in a patient with variant Glanzmann Thrombasthenia severely affects integrin alphaIIBbeta3 functions.
D'Andrea G; Bafunno V; Del Vecchio L; Amoriello A; Morabito P; Vecchione G; Grandone E; Margaglione M
Blood Coagul Fibrinolysis; 2008 Oct; 19(7):657-62. PubMed ID: 18832906
[TBL] [Abstract][Full Text] [Related]
18. Natural history of platelet antibody formation against αIIbβ3 in a French cohort of Glanzmann thrombasthenia patients.
Fiore M; Firah N; Pillois X; Nurden P; Heilig R; Nurden AT
Haemophilia; 2012 May; 18(3):e201-9. PubMed ID: 22250950
[TBL] [Abstract][Full Text] [Related]
19. SINE-VNTR-Alu retrotransposon insertion as a novel mutational event underlying Glanzmann thrombasthenia.
Zhang J; Tang J; Li G; Li N; Wang J; Yao R; Yu T
J Thromb Haemost; 2023 Dec; 21(12):3597-3607. PubMed ID: 37604334
[TBL] [Abstract][Full Text] [Related]
20. Two homozygous missense mutations in ITGB3 gene as a cause of Glanzmann Thrombasthenia in four consanguineous Pakistani pedigrees.
Ali T; Gul S; Amar A; Shakoor M; Farhan S; Mohsin S; Khaliq S
Int J Lab Hematol; 2020 Oct; 42(5):628-635. PubMed ID: 32558238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
